3658 results for «202»

Filter By

3658 results

Aneurysms and fistulas: contemporary approaches

21 May 2026 – From EuroPCR 2026

Focus on contemporary approaches to coronary aneurysms and fistulas, presenting complex interventional techniques and case-based strategies to overcome anatomical challenges and ensure effective treatment.

Haemodynamic support: from shock to complex high-risk interventional problems

21 May 2026 – From EuroPCR 2026

This session examines haemodynamic support from cardiogenic shock through to complex high-risk interventional cardiology procedures. It features registry data, clinical outcomes, and procedural techniques including mechanical circulatory support and arterial access strategies.

Navigating the complexity of high bleeding risk

20 May 2026 – From EuroPCR 2026

Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.

When the angiogram shows no answer for your AMI patient: what's next?

20 May 2026 – From EuroPCR 2026

This session focuses on non-occlusive causes of acute coronary syndromes (ACS) when angiograms do not reveal clear pathology. It emphasizes the diagnostic value of intracoronary imaging for conditions such as MINOCA and spontaneous coronary artery dissection (SCAD), and discusses optimal treatment strategies and prognostic considerations.

Stentless PCI, DCB and BVS in complex scenarios

20 May 2026 – From EuroPCR 2026

This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.

DCB - Going beyond in-stent restenosis

20 May 2026 – From EuroPCR 2026

This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.

New tools for risk stratification in STEMI

20 May 2026 – From EuroPCR 2026

This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.

How to achieve coronary patency during TAVI

21 May 2026 – From EuroPCR 2026

This session addresses techniques to achieve coronary artery patency during transcatheter aortic valve implantation (TAVI), highlighting advanced procedural approaches and management of high-risk anatomical scenarios.

Useful links in Interventional Cardiology

12 Oct 2016

We would like to share useful information and links to resources with you on Interventional Cardiology, medical professional societies, specialised websites and scoring tools.

PCR Webinars: Bringing the hot topics in interventional cardiology to your home

10 Jun 2024

According to Medical Director of PCR Webinars, Dejan Milasinovic, two novel additions to the platform will increase the interactive experience and take webinar­ based learning to a new level.

PCR Webinars: Bringing the hot topics in interventional cardiology to your home

The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

07 Apr 2024

Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.

Charles Fauvel

Author

Charles Fauvel
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES

14 May 2024

Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial

29 Oct 2024

Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.

Luigi Biasco

Author

Luigi Biasco
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

29 Mar 2025

Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.

Luigi Biasco

Author

Luigi Biasco
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

09 Mar 2026

Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!

Jonathan Curio

Author

Jonathan Curio

Author

Matti Adam
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

30 Oct 2024

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Author

Ali Nazmi Calik
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
Didn’t find what you were looking for?